Oligonucleotide CDMO Market Set for Explosive Growth: Reaching USD 6.73 Billion by 2029
The global Oligonucleotide CDMO Market is entering a high-growth phase, driven by the accelerating adoption of oligonucleotide-based therapeutics, rising outsourcing trends, and the rapid advancement of precision medicine. Valued at USD 2.33 billion in 2023, the market is projected to grow at an impressive CAGR of 21.8%, reaching USD 2.51 billion in 2024 and a remarkable USD 6.73 billion by...
0 Comments 0 Shares 62 Views 0 Reviews